Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M194Revenue $M6.3Net Margin (%)-409.9Altman Z-Score-52.1
Enterprise Value $M225EPS $-0.2Operating Margin %-352.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.8Pre-tax Margin (%)-409.9Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.6Cash flow > EarningsY
Price/Sales25.45-y EBITDA Growth Rate %57.7Current Ratio0.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-161.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M151ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with NAVB

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

NAVB is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NAVB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-05-01Sell12,500$1.33-3.01 view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-04-01Sell20,000$1.58-18.35 view
GOLDBERG MICHAEL MDirector 2014-11-14Buy100,000$1.0819.44 view
FORD BRENDAN ADirector 2014-11-10Buy10,000$1.0325.24 view
Nordlicht Mark10% Owner 2014-09-02Sell60,000$1.36-5.15 view
Regan William J.SVP-Global Reg Affairs&Quality 2014-05-12Buy5,000$1.43-9.79 view
PYKETT MARK JEROMECEO 2014-05-09Buy10,000$1.34-3.73 view
PYKETT MARK JEROMECEO 2014-03-10Sell120,000$1.96-34.18 view
LARSON BRENT LEVP, CFO, Treas & Secy 2014-03-10Sell41,500$1.96-34.18 view
Cope Frederick OSVP 2014-03-10Sell15,000$1.96-34.18 view

Press Releases about NAVB :

    Quarterly/Annual Reports about NAVB:

    News about NAVB:

    Articles On GuruFocus.com
    Navidea Biopharmaceuticals Reports 4 Insider Trades Mar 18 2013 
    comment on NAVB Mar 15 2013 

    More From Other Websites
    Navidea Biopharmaceuticals to Present at Jefferies Global Healthcare Conference May 26 2015
    Navidea Biopharmaceuticals to Present at Jefferies Global Healthcare Conference May 26 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement,... May 21 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Financials May 20 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... May 15 2015
    10-Q for Navidea Biopharmaceuticals, Inc. May 13 2015
    Navidea Biopharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today May 12 2015
    Navidea Reports First Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek® Revenue Guidance May 12 2015
    Navidea reports 1Q loss May 12 2015
    Navidea reports 1Q loss May 12 2015
    Navidea Reports First Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek® Revenue Guidance May 12 2015
    Q1 2015 Navidea Biopharmaceuticals Inc Earnings Release - Before Market Open May 12 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 11 2015
    Navidea Secures $60 Million Loan with CRG; Funding to Support Lymphoseek® Commercialization and... May 11 2015
    Navidea Secures $60 Million Loan with CRG; Funding to Support Lymphoseek® Commercialization and... May 11 2015
    10-K for Navidea Biopharmaceuticals, Inc. May 04 2015
    Navidea Biopharmaceuticals to Announce First Quarter 2015 Financial Results on May 12, 2015 Apr 30 2015
    Navidea Biopharmaceuticals to Announce First Quarter 2015 Financial Results on May 12, 2015 Apr 30 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Apr 27 2015
    Navidea Divests NAV5001, a Non-Core, Development-Stage Imaging Agent for Parkinson's Disease Apr 27 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK